Efficient adenoviral gene transfer to early venous bypass grafts: Comparison with native vessels

Cardiovascular Research

Volumn 35, Issue 3, 1997, Pages 505-513

  Channon, Keith M ^a   Fulton, Gregory J ^b   Gray, John L ^b   Annex, Brian H ^a   Shetty, Geetha A ^a   Blazing, Michael A ^a   Peters, Kevin G ^a   Hagen, Per Otto ^b   George, Samuel E ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adenovirus; Bypass grafts; Endothelium; Gene transfer; Rabbit, endothelial cells; Smooth muscle

Indexed keywords

VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; CONTROLLED STUDY; GENE TRANSFER; GRAFT FAILURE; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; VEIN BYPASS; VEIN GRAFT;

ADENOVIRIDAE; ANIMALS; BETA-GALACTOSIDASE; CAROTID STENOSIS; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; IMMUNOHISTOCHEMISTRY; JUGULAR VEINS; MALE; MUSCLE, SMOOTH, VASCULAR; RABBITS; TIME FACTORS;

EID: 0030828750     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00098-9     Document Type: Article

References (38)

1. Davies M.G., Hagen P.-O. Pathophysiology of vein graft failure: a review. Eur J Endovasc Surg. 9:1995;7-18.
2. Ip J.H., Fuster V., Badimon L., Badimon J., Taubman M.B., Chesebro J.H. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol. 15:1990;1667-1687.
3. Bulkley B.H., Hutchins G.M. Accelerated 'atherosclerosis': a morphologic study of 97 saphenous vein coronary artery bypass grafts. Circulation. 55:1977;163-169.
4. Campeau L., Enjalbert M., Lesperance J., Vaislic C., Grondin C.M., Bourassa M.G. Atherosclerosis and the late closure of aortocoronary saphenous vein grafts: sequential studies at 2 weeks, 1 year, 5-7 years and 10-12 years after surgery. Circulation. 68(suppl II):1983;1-7.
5. Goldman S., Copeland J., Moritz T.et al. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a veterans administration cooperative study. Circulation. 80:1989;1190-1197.
6. Nabel E.G., Pompili V.J., Plautz G.E., Nabel G.J. Gene transfer and vascular disease. Cardiovasc Res. 28:1994;445-455.
7. Isner J.M., Feldman L.J. Gene therapy for arterial disease. Lancet. 344:1995;1653-1655.
8. Ali M., Lemoine N.R., Ring C.J.A. The use of DNA viruses as vectors for gene therapy. Gene Ther. 1:1994;367-384.
9. Channon K.M., Blazing M.A., George S.E. Vascular gene transfer. Heart. 85:1996;215-217.
10. Ohno T., Gordon D., San H.et al. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science. 265:1994;781-784.
11. Chang M.W., Barr E., Seltzer J.et al. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science. 267:1995;518-522.
12. Simari R.D., San H., Rekhter M.et al. Regulation of cellular proliferation and intimal formation following balloon injury in atherosclerotic rabbit arteries. J Clin Invest. 98:1996;225-235.
13. Riessen R., Isner J.M. Prospects for site-specific delivery of pharmacologic and molecular therapies. J Am Coll Cardiol. 23:1994;1234-1244.
14. Willard J.E., Landau C., Glamann D.B.et al. Genetic modification of the vessel wall: Comparison of surgical and catheter-based techniques for delivery of recombinant adenovirus. Circulation. 89:1994;2190-2197.
15. French B.A., Mazur W., Ali N.M.et al. Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis. Circulation. 90:1994;2402-2413.
16. Landau C., Pirwitz M.J., Willard M.A., Gerard R.D., Meidell R.S., Willard J.E. Adenoviral mediated gene transfer to atherosclerotic arteries after balloon angioplasty. Am Heart J. 129:1995;1051-1057.
17. Feldman L.J., Steg P.G., Zheng L.P.et al. Low-efficiency of percutaneous adenovirus-mediated arterial gene transfer in the atherosclerotic rabbit. J Clin Invest. 95:1995;2662-2671.
18. Chen S.J., Wilson J.M., Muller D.W. Adenovirus-mediated gene transfer of soluble vascular cell adhesion molecule to porcine interposition vein grafts. Circulation. 89:1994;1922-1928.
19. Rome J.J., Shayani V., Flugelman M.Y.et al. Anatomic barriers influence the distribution of in vivo gene transfer into the arterial wall. Modeling with microscopic tracer particles and verification with a recombinant adenoviral vector. Arterioscler Thromb. 14:1994;148-161.
20. Schulick A.H., Dong G., Virmani R., Dichek D.A. Enodothelium-specific in-vivo gene transfer. Circ Res. 77:1995;475-485.
21. Davies M.G., Klyachkin M.L., Dalen H., Massey M.F., Svendsen E., Hagen P.-O. The integrity of experimental vein graft endothelium-implications on the etiology of early vein graft failure. Eur J Vasc Surg. 7:1993;156-165.
22. Channon KM, Fulton GJ, Davies MG, et al. Modulation of tissue factor protein expression in experimental venous bypass grafts. Arterioscler Thromb Vasc Biol 1997;(in press).
23. Jones N., Shenk T. Isolation of deletion and substitution mutants of adenovirus type 5. Cell. 13:1978;181-188.
24. Channon K.M., Blazing M.A., Shetty G.A., Potts K.E., George S.E. Adenoviral gene transfer of nitric oxide synthase: high level expression in human vascular cells. Cardiovasc Res. 32:1996;962-972.
25. Graham FL, Prevec L. Methods in molecular biology, vol. 7: gene transfer and expression protocols. Clifton, NJ: Humana Press, Inc., 1991:109-128.
26. Davies M.G., Kim J.H., Dalen H., Makhoul R.G., Svendsen E., Hagen P.-O. Reduction of experimental vein graft intimal hyperplasia and preservation of nitric-oxide mediated relaxation by the nitric oxide precursor L-arginine. Surgery. 116:1994;557-568.
27. Galea-Lauri J., Blackford J., Wilkinson J.M. The expression of CD11/CD18 molecules on rabbit leukocytes: identification of monoclonal antibodies to CD18 and their effect on cellular adhesion processes. Mol Immunol. 30:1993;529-537.
28. Dumont D.J., Yamaguchi T.P., Conlon R.A., Rossant J., Brietman M.L. Tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in mouse endothelial cells and their presumptive precursors. Oncogene. 7:1992;1471-1480.
29. Tanaka H., Sukhova G.K., Swanson S.J.et al. Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury. Circulation. 88:1993;1788-1803.
30. Lemarchand P., Jones M., Yamada I., Crystal R.G. In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors. Circ Res. 72:1993;1132-1138.
31. Steg P.G., Feldman L.J., Scoazec J.-Y.et al. Arterial gene transfer to rabbit endothelial and smooth muscle cells using percutaneous delivery of an adenoviral vector. Circulation. 90:1994;1648-1656.
32. Schulick A.H., Newman K.D., Virmani R., Dichek D.A. In vivo gene transfer into injured carotid arteries: Optimization and evaluation of acute toxicity. Circulation. 91:1995;2407-2414.
33. Lee S.W., Trapnell B.C., Rade J.J., Virmani R., Dichek D.A. In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries. Circ Res. 73:1993;797-807.
34. Wang Q., Jia X.C., Finer M.H. A packaging cell line for propagation of recombinant adenovirus vectors containing two lethal gene-region deletions. Gene Ther. 2:1995;775-783.
35. Yang Y., Nunes F.A., Berencsi K., Gonczol E., Engelhardt J.F., Wilson J.M. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat Genet. 7:1994;362-369.
36. Wang Q., Finer M.H. Second-generation adenovirus vectors. Nat Med. 2:1996;714-716.
37. Channon KM, George SE. Improved adenoviral vectors: cautious optimism for for gene therapy. Q J Med 1997;90:105-109.
38. Newman K.D., Dunn P.F., Owens J.W.et al. Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J Clin Invest. 96:1995;2955-2965.